Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03637972 · ClinicalTrials.gov registry record · Phase 3
COMET2 Project 1 Filter Ventilation Study
A Phase 3 study, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 118
- Enrollment target
NCT03637972 is a Phase 3 study that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 118 participants.
The verdict
NCT03637972, a Phase 3 study, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 118 participants
- Enrollment target
Study Summary
Phase III randomized, 2 x 2 design, open label, multi-center study that will assess the removal of filter ventilation on smoking behavior and biomarkers in a tobacco and nicotine product marketplace simulation of a real world environment.
Interventions
- OTHER Ventilated cigarettes only
- OTHER Unventilated cigarettes only
- OTHER Access to Experimental Marketplace: Ventilated cigarettes + alternative nicotine delivery systems
- OTHER Access to Experimental Marketplace: Unventilated cigarettes + ANDS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2018-10-18 |
| Est. Completion | 2021-12-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03637972
The ClinicalTrials.gov registry entry for NCT03637972 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ventilated cigarettes only is the first listed.
NCT03637972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03637972 about?
NCT03637972 is a clinical study titled "COMET2 Project 1 Filter Ventilation Study". Phase III randomized, 2 x 2 design, open label, multi-center study that will assess the removal of filter ventilation on smoking behavior and biomarkers in a tobacco and nicotine product marketplace simulation of a real world environment.
What is the current status of trial NCT03637972?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 118 participants. The study started on 2018-10-18. Estimated completion is 2021-12-09.
What interventions are being tested in trial NCT03637972?
The interventions under investigation include: Ventilated cigarettes only (OTHER), Unventilated cigarettes only (OTHER), Access to Experimental Marketplace: Ventilated cigarettes + alternative nicotine delivery systems (OTHER), Access to Experimental Marketplace: Unventilated cigarettes + ANDS (OTHER).
Who is sponsoring clinical trial NCT03637972?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.